ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 271 filers reported holding ICU MED INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,268,737 | +223.3% | 11,822 | +200.5% | 0.11% | +211.4% |
Q4 2023 | $392,377 | -74.0% | 3,934 | -69.0% | 0.04% | -80.6% |
Q3 2023 | $1,507,857 | +66.2% | 12,670 | +148.9% | 0.18% | +11.1% |
Q2 2023 | $906,987 | -34.5% | 5,090 | -39.4% | 0.16% | -37.2% |
Q1 2023 | $1,385,664 | +101.5% | 8,400 | +92.4% | 0.26% | +57.3% |
Q4 2022 | $687,558 | +40.0% | 4,366 | +46.2% | 0.16% | +24.2% |
Q2 2022 | $491,000 | -1.8% | 2,987 | +32.9% | 0.13% | -2.2% |
Q1 2022 | $500,000 | -51.9% | 2,248 | -49.5% | 0.14% | -60.2% |
Q3 2021 | $1,039,000 | +118.7% | 4,450 | +71.2% | 0.34% | -4.2% |
Q3 2020 | $475,000 | +21.5% | 2,600 | +22.4% | 0.35% | -28.5% |
Q2 2020 | $391,000 | -64.7% | 2,124 | -54.1% | 0.50% | -9.0% |
Q1 2019 | $1,107,000 | +164.2% | 4,626 | +211.9% | 0.54% | +90.9% |
Q3 2018 | $419,000 | +82.2% | 1,483 | +89.4% | 0.28% | +61.0% |
Q2 2018 | $230,000 | +8.0% | 783 | -59.8% | 0.18% | +24.6% |
Q3 2015 | $213,000 | -85.7% | 1,948 | -91.1% | 0.14% | -51.4% |
Q3 2013 | $1,491,000 | – | 21,943 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |